Nel ASA Investors Await Key Spring Updates

Nel's pivotal 2026 events will show if its strategic shift, marked by a 364% order surge and new gigawatt factory, is paying off after a tough 2025.

Two significant events in April will provide crucial insights into the strategic progress of Norwegian electrolyzer manufacturer Nel ASA. The company’s annual general meeting on April 10th and the subsequent release of its first-quarter 2026 results on April 22nd are poised to reveal whether its extensive restructuring efforts are beginning to yield results. This follows a challenging 2025 fiscal year characterized by substantial write-downs and declining revenue.

A Pivotal Restructuring Year

Fiscal year 2025 represented a fundamental transition for Nel. Revenue contracted by 31% to 963 million Norwegian kroner (NOK). This decline was not primarily due to operational shortcomings but rather a deliberate strategic shift. The company recorded a 799 million NOK impairment charge on production equipment and intangible assets, signaling a decisive move away from its first-generation alkaline electrolysis technology. Concurrently, workforce reductions from 430 to 346 full-time positions lowered personnel expenses by 12% to 569 million NOK.

Despite these financial pressures, Nel concluded the fourth quarter with a remarkable surge in new orders. Order bookings skyrocketed 364% year-over-year to 686 million NOK, boosting the total order backlog to 1,319 million NOK. This backlog includes the largest PEM electrolyzer contract in the company's history: a 40-megawatt system for HYDS, to be deployed across two sites in Norway.

Financial Position and the Path to Profitability

Nel’s balance sheet shows it entered the new year with a solid liquidity position of approximately 1.6 billion NOK in cash and equivalents. While this marks a decrease from the 1.9 billion NOK held at the end of 2024, management believes it is sufficient to fund the coming phase of its strategic plan. The company reported a negative EBITDA of around 275 million NOK for the year, underscoring the distance still to travel on the road to sustained profitability.

The forthcoming annual general meeting will give shareholders a formal platform to engage with the board and executive team on the timeline for new product launches and the details of the company's liquidity management. The Q1 report two weeks later will offer early indicators of Nel's ability to convert its expanding order book into recognized revenue.

The Herøya Facility: Cornerstone of the New Strategy

At the heart of Nel's transformation is the scaling of its new "Next Generation Pressurized Alkaline" platform at the Herøya plant. In December 2025, the board approved the industrialization of this technology, under development since 2018. The initial phase targets a one-gigawatt manufacturing capacity and requires an investment of roughly 300 million NOK. This cost is partially offset by an EU grant of up to 135 million euros, covering about 60% of eligible expenses. The long-term ambition is for Herøya to achieve an annual output capacity of four gigawatts.

The new platform promises significant advantages over its predecessor, including a system footprint up to 80% smaller and a projected cost reduction of 40-60%. The commercial rollout, scheduled for the first half of 2026, will test these promises at scale, with larger volume deliveries planned from 2027 onward.

Investors are now focused on how management will navigate the capital expenditure requirements for Herøya across 2026 and 2027 while steering the company toward its promised efficiency gains and market leadership. The April meetings will be critical for assessing the execution of this complex strategic pivot.